Print

IAVI 016

Phase I double-blind, randomized, placebo-controlled study to evaluate peak T cell response times to either a HIV-1 Clade A MVA vaccine given alone or a prime-boost regimen of a high dose of an HIV-1 Clade A DNA vaccine and an HIV-1 Clade A MVA vaccine

Trial Details:

I Completed
International AIDS Vaccine Initiative (IAVI) February 01, 2004
DNA.HIVA ,MVA.HIVA Pox Gag A; DNA Gag A
MVA.HIVA Viral Vector - Pox
DNA.HIVA DNA
MVA.HIVA Viral Vector - Pox
United Kingdom 24